Correlation Between Pharmaceuticals Ultrasector and Profunds Ultrashort

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Profunds Ultrashort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Profunds Ultrashort into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Profunds Ultrashort Nasdaq 100, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Profunds Ultrashort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Profunds Ultrashort. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Profunds Ultrashort.

Diversification Opportunities for Pharmaceuticals Ultrasector and Profunds Ultrashort

-0.78

Correlation Coefficient

Pharmaceuticals Ultrasector  Profunds Ultrashort

Pay attention - limited upside

The 3 months correlation between Pharmaceuticals and Profunds is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Profunds Ultrashort Nasdaq 100 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Profunds Ultrashort and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Profunds Ultrashort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Profunds Ultrashort has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Profunds Ultrashort go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Profunds Ultrashort

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 1.08 times more return on investment than Profunds Ultrashort. However, Pharmaceuticals Ultrasector is 1.08 times more volatile than Profunds Ultrashort Nasdaq 100. It trades about 0.22 of its potential returns per unit of risk. Profunds Ultrashort Nasdaq 100 is currently generating about -0.23 per unit of risk. If you would invest  2,129  in Pharmaceuticals Ultrasector Profund on May 22, 2025 and sell it today you would earn a total of  513.00  from holding Pharmaceuticals Ultrasector Profund or generate 24.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Profunds Ultrashort Nasdaq 100

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 17 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Profunds Ultrashort

Risk-Adjusted Performance

Weakest

Over the last 90 days Profunds Ultrashort Nasdaq 100 has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Pharmaceuticals Ultrasector and Profunds Ultrashort

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Profunds Ultrashort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Profunds Ultrashort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profunds Ultrashort will offset losses from the drop in Profunds Ultrashort's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Profunds Ultrashort Nasdaq 100 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.